Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Nature Communications|November 23, 2021
A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patientsSynne Jenum, Kristian Tonby, Corina S Rueegg, et al.
Archives of Neurology|April 18, 2012
ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trialOivind Torkildsen, Stig Wergeland, Søren Bakke, et al.
Annals of the Rheumatic Diseases|August 18, 2017
Calprotectin as a marker of inflammation in patients with early rheumatoid arthritisMaria Karolina Jonsson, Nina Paulshus Sundlisæter, Hilde Haugedal Nordal, et al.
Journal of Internal Medicine|April 12, 2022
Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trialMarthe Kirkesaether Brun, Guro Løvik Goll, Kristin Kaasen Jørgensen, et al.
Annals of the Rheumatic Diseases|June 19, 2015
First step in the development of an ultrasound joint inflammation score for rheumatoid arthritis using a data-driven approachAnna-Birgitte Aga, Hilde Berner Hammer, Inge Christoffer Olsen, et al.
RMD Open|January 12, 2017
Development of a feasible and responsive ultrasound inflammation score for rheumatoid arthritis through a data-driven approachAnna-Birgitte Aga, Hilde Berner Hammer, Inge Christoffer Olsen, et al.
Pageof 5